Head to head
Lumecca vs OptiLIGHT (2026)
Compare purchase costs, running costs and the evidence behind each device.
Read the comparison overview
- Purchase cost
- No new-price range is on file for either Lumecca or OptiLIGHT. Request current quotes to compare purchase costs.
- Practice fit
- Lumecca: IPL handpiece/system. OptiLIGHT: IPL platform. Check each model’s US regulatory status and labeled indications for your intended use.
IPL handpiece/system
View full device profile →IPL platform
View full device profile →Price comparison
New price range
- InMode Lumecca / Lumecca Peak
- Not published
- Lumenis OptiLIGHT
- Not published
Used asking range
- InMode Lumecca / Lumecca Peak
- handpiece $8k-$11,792; Optimas platform carrying Lumecca $22k-$33,975Reported source: Used listing · Aug 30, 2026
- Lumenis OptiLIGHT
- Not published
Payback calculator
- InMode Lumecca / Lumecca Peak
- View ROI calculator
- Lumenis OptiLIGHT
- View cost details
Next step
Consumable economics
Consumable cost / lock-in
- InMode Lumecca / Lumecca Peak
- —
- Lumenis OptiLIGHT
- —
Service cost
- InMode Lumecca / Lumecca Peak
- Not published
- Lumenis OptiLIGHT
- Not published
FDA clearance
FDA status & indication
- InMode Lumecca / Lumecca Peak
Read FDA indication wording
“The InMode SR IPL Device wavelengths (515-l200nm) are indicated for use for the following treatments: " The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); " The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations.”
- Lumenis OptiLIGHT
- FDA ClearedDe Novo: DEN200028, K193500
Read FDA indication wording
“Universal IPL with a spectrum of 400-1200nm (with different filters) is indicated for: Improvement of signs of Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye, in patients 22 years of age and older with moderate to severe signs and symptoms of DED due to MGD and with Fitzpatrick skin types I-IV. IPL is to be applied only to skin on the malar region of the face, from tragus to tragus including the nose (eyes should be fully covered by protective eyewear). IPL is intended to be applied as an adjunct to other modalities, such as meibomian gland expression, artificial tear lubricants and warm compresses.”
Which chains run each
Chain adoption
- InMode Lumecca / Lumecca Peak
- 0 recorded pairings
- Lumenis OptiLIGHT
- 0 recorded pairings
Chains using it
- InMode Lumecca / Lumecca Peak
- —
- Lumenis OptiLIGHT
- —
Approved reviews
- InMode Lumecca / Lumecca Peak
- 0
- Lumenis OptiLIGHT
- 0
Specs and platform
Manufacturer
- InMode Lumecca / Lumecca Peak
- InMode
- Lumenis OptiLIGHT
- Lumenis
Built by (OEM)
- InMode Lumecca / Lumecca Peak
- InMode Ltd.
- Lumenis OptiLIGHT
- Lumenis Be Ltd.
Category
- InMode Lumecca / Lumecca Peak
- IPL handpiece/system
- Lumenis OptiLIGHT
- IPL platform
Technology
- InMode Lumecca / Lumecca Peak
- High peak-power IPL 515/580nm (IPL)
- Lumenis OptiLIGHT
- Optimal Pulse Technology IPL (IPL)
Launch year
- InMode Lumecca / Lumecca Peak
- 2016
- Lumenis OptiLIGHT
- —
Status
- InMode Lumecca / Lumecca Peak
- Current
- Lumenis OptiLIGHT
- Current
Manufacturer source record
- InMode Lumecca / Lumecca Peak
- No linked source on file.
- Lumenis OptiLIGHT
- No linked source on file.
Current alternatives
Current catalog models in related categories. Confirm availability and configuration with the supplier.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.